Grapefruit derived flavonoid naringin improves ketoacidosis and lipid peroxidation in type 1 diabetes rat model

PLoS ONE

Volumn 11, Issue 4, 2016, Pages

  Murunga, Alfred N ^a   Miruka, David O ^a   Driver, Christine ^a   Nkomo, Fezile S ^a   Cobongela, Snazo Z Z ^a   Owira, Peter M O ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; ACETOACETIC ACID; AURANTIIN; BICARBONATE; GLYCOGEN; INSULIN; LIPID; MALONALDEHYDE; PIG INSULIN; FLAVANONE DERIVATIVE; GLUCOSE BLOOD LEVEL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIABETIC KETOACIDOSIS; DRUG EFFECT; DRUG MECHANISM; FLUID INTAKE; GLUCOSE INTOLERANCE; HYPERGLYCEMIA; INSULIN BLOOD LEVEL; INSULIN DEPENDENT DIABETES MELLITUS; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; POLYDIPSIA; POLYURIA; RAT; URINE VOLUME; WEIGHT REDUCTION; ANIMAL; BLOOD; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; DRUG EFFECTS; GLUCOSE BLOOD LEVEL; GRAPEFRUIT; KETOSIS; METABOLISM; SPRAGUE DAWLEY RAT;

ANIMALS; BLOOD GLUCOSE; CITRUS PARADISI; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FLAVANONES; GLUCOSE INTOLERANCE; INSULIN; KETOSIS; LIPID PEROXIDATION; MALE; MALONDIALDEHYDE; OXIDATIVE STRESS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84963736217     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0153241     Document Type: Article

References (34)

1. Wild Sarah, Roglic Gojka, Green Anders, Sicree Richard, King Hilary. Global Prevalence of Diabetes Estimates for the year 2000 and projections for 2030. Diabetes Care 2004; 27(5):1047-1053. PMID: 15111519
2. Alberti KGMM and Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus. Provisional report of a WHO Consultation. Diabetic Medicine 1998; 15(7);539-553. PMID: 9686693
3. Usher-Smith JA, Thompson MJ and Walter FM. Factors associated with the presence of diabetic ketoacidosis at diagnosis of diabetes in children and young adults: A systematic review. BMJ 2011; 343: D4092. doi: 10.1136/bmj.d4092 PMID: 21737470
4. Wolfsdorf J, Craig ME, Daneman D, Dunger D, Edge J, Lee W, et al. Diabetic ketoacidosis in children and adolescents with diabetes. Pediatric Diabetes 2009; 10:118-133. doi: 10.1111/j.1399-5448.2009. 00569.x PMID: 19754623
5. Diagnosis and classification of diabetes mellitus. Diabetes Care 2010; 33 Suppl 1:S62-S69. doi: 10. 2337/dc10-S062 PMID: 20042775
6. Murunga AN. and Owira PMO. Diabetic ketoacidosis: An overlooked child killer in sub-Saharan Africa? Tropical Medicine and International Health 2013; 18(11):1357-1364. doi: 10.1111/tmi.12195 PMID: 24112393
7. Casteels K. and Mathieu C. Diabetic Ketoacidosis. Reviews in Endocrine & Metabolic Disorders 2003; 4(2): 159-166.
8. Chiasson JL, Aris-Jilwan N, Bélanger R, Bertrand S, Beauregard H, Ekoé JM et al. Diagnosis and treatment of diabetic ketoacidosis and the hyperglycemic hyperosmolar state. CMAJ: Canadian Medical Association Journal 2003; 168(7):859-866. PMID: 12668546
9. McPherson P and McEneny J. The biochemistry of ketogenesis and its role in weight management, neurological disease and oxidative stress. Journal of Physiology and Biochemistry 2012; 68(1):141-151. doi: 10.1007/s13105-011-0112-4 PMID: 21983804
10. Vladimir S. and Sherri I. Role of beta-hydroxybutyric acid in diabetic ketoacidosis: A review. Can Vet J 2011; 52:426-430. PMID: 21731100
11. Kraut JA and Madias NE. Serum anion gap: Its uses and limitations in clinical medicine. Clin J Am Soc Nephrol 2007; 2(1): 162-74. PMID: 17699401
12. Rewers A. Current concepts and controversies in prevention and treatment of diabetic ketoacidosis in children. Current Diabetes Reports 2012; 12, 524-532. doi: 10.1007/s11892-012-0307-2 PMID: 22864672
13. Xulu S. and Owira PMO. Naringin ameliorates atherogenic dyslipidemia but not hyperglycemia in rats with type 1 diabetes. J Cardiovasc Pharmacol 2012; 59(2):133-41. doi: 10.1097/FJC. 0b013e31823827a4 PMID: 21964158
14. Alam MA, Subhan N, Rahman MM, Uddin SJ, Reza HM, Sarker SD. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Adv Nutr. 2014 Jul 14; 5 (4):404-17. doi: 10.3945/an.113.005603 PMID: 25022990
15. Punithavathi VR, Anuthama R, Prince PSM. Combined treatment with naringin and vitamin C ameliorates streptozotocin-induced diabetes in male Wistar rats. Journal of Applied Toxicology 2008; 28 (6):806-813. doi: 10.1002/jat.1343 PMID: 18344197
16. Mahmoud AM, Ashour MB, Abdel-Moneim A, Ahmed OM. Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J Diabetes Complications 2012; 26(6):483-90. doi: 10.1016/j. jdiacomp.2012.06.001 PMID: 22809898
17. Jung UJ, Lee MK, Jeong KS, Choi MS. The Hypoglycemic effects of hesperidin and naringin are partly mediated by hepatic glucose-regulating enzymes in C57BL/KsJ-db/db Mice. The Journal of Nutrition 2004; 134(10):2499-2503. PMID: 15465737
18. Ali MM, El Kader MA. The influence of naringin on the oxidative state of rats with streptozotocin-induced acute hyperglycaemia. Z Naturforsch C 2004; 59:726-33. PMID: 15540607
19. Anandh Babu PV, Sabitha KE, Shyamaladevi CS. Green Tea Extracts Impedes Dyslipidemia and Development of Cardiac Dysfunction In Streptozotocin-Diabetic Rats Clinical and Experimental Pharmacology and Physiology 2006; 33(12):1184-1189. PMID: 17184499
20. Seifter S. and Dayton S. The estimation of glycogen with the anthrone reagent. Arch Biochem 1950; 25 (1):191-200. PMID: 15401229
21. Phulukdaree A, Moodely D, Chuturgoon AA. The Effects of Sutherlandia frutescens extracts in cultured renal proximal and distal tubule epithelial cells. S Afr J Sci 2010; 106:1-5.
22. Parmar HS, Jain P, Chauhan DS, Bhinchar MK, Munjal V, Yusuf M, Choube K, Tawani A, Tiwari V, Manivannan E, Kumar A. DPP-IV inhibitory potential of naringin: An in silico, in vitro and in vivo study. Diabetes Res Clin Pract. 2012 Jul; 97(1):105-11. doi: 10.1016/j.diabres.2012.02.011 PMID: 22410395
23. Arai S, Stotts N, Puntillo K. Thirst in Critically Ill Patients: From Physiology to Sensation. Am J Crit Care 2013; 22(4):328-335. doi: 10.4037/ajcc2013533 PMID: 23817822
24. Jung UJ, Lee MK, Park YB, Kang MA, Choi MS. Effect of citrus flavonoids on lipid metabolism and glucose-regulating enzyme mRNA levels in type-2 diabetic mice. Int J Biochem Cell Biol 2006; 38 (7):1134-45. PMID: 16427799
25. Shulman RG, Bloch G, Rothman DL. In vivo regulation of muscle glycogen synthase and the control of glycogen synthesis. Proceedings of the National Academy of Sciences 1995; 92(19):8535-8542.
26. Zygmunt K, Faubert B, MacNeil J, Tsiani E. Naringenin, a citrus flavonoid, increases muscle cell glucose uptake via AMPK; Biochem Biophys Res Commun 2010; 398(2):178-83. doi: 10.1016/j.bbrc. 2010.06.048 PMID: 20558145
27. Pu P, Gao DM, Mohamed S, Chen J, Zhang J, Zhou XY et al. Naringin ameliorates metabolic syndrome by activating AMP-activated protein kinase in mice fed a high-fat diet Arch Biochem Biophys 2012; 518 (1):61-70]. doi: 10.1016/j.abb.2011.11.026 PMID: 22198281
28. Fiorentino TV, Prioletta A, Zuo P, Folli F. Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases. Curr Pharm Des 2013; 19(32):5695-703. PMID: 23448484
29. Niki E. Lipid peroxidation products as oxidative stress biomarkers. Biofactors 2008; 34(2):171-80. PMID: 19706982
30. Hayanga JA, - Ngubane SP, -Murunga AN, Owira PMO. Grapefruit juice improves glucose intolerance in streptozotocin?induced diabetes by suppressing hepatic gluconeogenesis. Eur J Nutr. 2016 Mar; 55 (2):631-8. doi: 10.1007/s00394-015-0883-4 PMID: 25792078
31. Li P, Wang S, Guan X, Cen X, Hu C, Peng W, Wang Y, Su W. Six months chronic toxicological evaluation of naringin in Sprague-Dawley rats. Food Chem Toxicol. 2014 Apr; 66:65-75. doi: 10.1016/j.fct. 2014.01.023 PMID: 24462649
32. Alam MA, Subhan N, Rahman MM, Uddin SJ, Reza HM, Sarker SD. Effect of citrus flavonoids, naringin and naringenin, on metabolic syndrome and their mechanisms of action. Adv Nutr. 2014 Jul 14; 5 (4):404-17. doi: 10.3945/an.113.005603 PMID: 25022990
33. Adebiyi OO, Adebiyi OA, Owira PM. Naringin Reverses Hepatocyte Apoptosis and Oxidative Stress Associated with HIV-1 Nucleotide Reverse Transcriptase Inhibitors-Induced Metabolic Complications. Nutrients. 2015 Dec 10; 7(12):10352-68. doi: 10.3390/nu7125540 PMID: 26690471
34. Adebiyi OO, Adebiyi OA, Owira PMO. Naringin mitigates cardiac hypertrophy by reducing oxidative stress and inactivating c-Jun Nuclear Kinase (JNK-1) protein in type I diabetes. J Cardiovasc Pharmacol. 2016 Feb; 67(2):136-44. doi: 10.1097/FJC.0000000000000325 PMID: 26421421